Q4 2024 Holdings
Filed 2025-02-14 | 53 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.1B | 19,751,284 | 36.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $207.7M | 5,161,801 | 7.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $182.9M | 4,181,179 | 6.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $117.4M | 1,388,064 | 4.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $115.6M | 2,796,513 | 3.9% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $95.5M | 3,633,743 | 3.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $73.3M | 1,900,015 | 2.5% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $72.8M | 10,400,158 | 2.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $70.0M | 5,750,683 | 2.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $63.1M | 4,308,935 | 2.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $56.2M | 2,452,024 | 1.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $54.8M | 3,944,194 | 1.9% |
| AC Immune SA(ACIU) | SHS | H00263105 | $52.7M | 19,522,436 | 1.8% |
| Xencor Inc(XNCR) | COM | 98401F105 | $52.6M | 2,288,760 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $48.0M | 1,771,417 | 1.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $45.4M | 3,466,000 | 1.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $43.2M | 1,569,422 | 1.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $38.9M | 6,904,050 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $35.9M | 7,000,000 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $35.3M | 1,073,755 | 1.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $33.9M | 4,333,885 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $33.3M | 5,715,893 | 1.1% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $29.4M | 1,092,796 | 1.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $25.9M | 6,293,282 | 0.9% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $25.0M | 5,302,000 | 0.8% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $24.4M | 2,372,933 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $22.4M | 2,567,469 | 0.8% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $20.0M | 16,552,417 | 0.7% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $19.2M | 2,764,471 | 0.7% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $17.9M | 2,325,000 | 0.6% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $15.7M | 8,748,629 | 0.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $14.9M | 2,670,642 | 0.5% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $14.6M | 9,237,556 | 0.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $14.0M | 2,106,037 | 0.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $13.5M | 10,333,600 | 0.5% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $13.5M | 594,282 | 0.5% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $10.9M | 2,100,468 | 0.4% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $9.1M | 2,989,474 | 0.3% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $8.9M | 8,902,972 | 0.3% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $8.4M | 696,555 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $7.7M | 1,036,679 | 0.3% |
| Ikena Oncology Inc | COM | 45175G108 | $6.6M | 4,006,564 | 0.2% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $6.5M | 1,353,968 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.4M | 5,228,461 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $3.6M | 3,853,818 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $3.5M | 917,826 | 0.1% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $3.1M | 1,813,633 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $2.4M | 9,544,262 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $2.1M | 339,549 | 0.1% |
| Elevation Oncology Inc | COM | 28623U101 | $1.7M | 2,966,836 | 0.1% |